Fernanda de Lima Ferreira

drug safety pharmacovigilance pharmacoepidemiology pbrer ich anvisa pharmaceutical regulatory regulations sae icsr narratives serious adverse event narratives ema cfr-21 volume 9a fda inspections audits epidemiology confounding variables epidemiologic studies adverse events post-marketing surveillance